LoQueEstaPasandoWorld news, seen from every angle
LIVE
Health

Amplia gets nod for new cancer drug trial ahead of US push

Amplia Therapeutics has received ethics approval for its ACCENT-Mini pancreatic cancer trial, paving the way to test daily doses of its narmafotinib drug alongside chemotherapy.

Reported by The Sydney Morning Herald. We will add other newspapers as they cover it.

How the newspaper covers this story

  1. The Sydney Morning HeraldAustralia

    Amplia gets nod for new cancer drug trial ahead of US push

    Amplia Therapeutics has received ethics approval for its ACCENT-Mini pancreatic cancer trial, paving the way to test daily doses of its narmafotinib drug alongside chemotherapy.

Related stories